Nvidia debuts 25 Generative AI Microservices for Healthcare Innovation

28/03/2024

NVIDIA debuts 25 Generative AI Microservices for Healthcare Innovation

At Nvidia’s annual GTC Conference, the company announced the launch of more than two dozen AI microservices built to help pharma companies streamline drug discovery, medical imaging, genomics, and digital human initiatives. In collaboration with Johnson & Johnson MedTech, and the Novo Nordisk Foundation, Nvidia aims to revolutionize drug discovery and medical innovation by building healthcare-oriented supercomputers. Around 100 companies like Astellas Pharma US Pharma and Amgen are already utilizing Nvidia’s BioNeMo AI platform microservices, spotlighting the industry-wide impact of its initiatives.

As supporters of innovation in the AI and healthcare sector, GlenFlow and our biotech startup OxyDial are excited to see the alignment of industry leaders and cutting-edge technology to drive transformative changes in the medical landscape, shaping the future of healthcare.